Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bioequivalence Study of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea on the Face

NCT02800148 is registered in ClinicalTrials.gov with Padagis LLC as lead sponsor.

NCT NCT02800148
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02800148 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bioequivalence Study of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea on the Face
Lead sponsor
Padagis LLC
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2016
Completion date
October 31, 2017
Enrollment
667 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rosacea